San Francisco, California--(Newsfile Corp. - April 10, 2025) - Shares of Zynex Inc. (NASDAQ: ZYXI), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% ...

TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical. In a recent filing with the Securities and ...

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Shares of Zynex Inc. (NASDAQ: ZYXI), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% over the past ...

Zynex Price Performance NASDAQ ZYXI opened at $2.16 on Tuesday. The company has a debt-to-equity ratio of 1.66, a quick ratio of 3.15 and a current ratio of 3.94. Zynex, Inc. has a 52-week low of ...

NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws ...

SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Zynex, Inc. (NASDAQ: ZYXI). The lawsuit seeks to ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or acquirers of Zynex, Inc. (NASDAQ: ZYXI) securities between March 13, 2023 and March 11, 2025, both dates inclusive ...

The information contained in this article is based on a press release statement from Zynex Inc. For comprehensive analysis and detailed insights, investors can access the full Pro Research Report, ...

SAN DIEGO, March 21, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Zynex, Inc. (NASDAQ ...

Revealing a significant insider sell on March 18, Thomas Sandgaard, President at Zynex ZYXI, as per the latest SEC filing. What Happened: Sandgaard's recent Form 4 filing with the U.S. Securities ...